Nkarta (NASDAQ:NKTX – Get Free Report) and TuHURA Biosciences (NASDAQ:HURA – Get Free Report) are both small-cap healthcare companies, but which is the superior investment? This is a summary of current recommendations and price targets for Nkarta and TuHURA Biosciences, as provided by MarketBeat. Given Nkarta’s stronger consensus rating and higher probable upside, research analysts clearly believe Nkarta is more favorable than TuHURA Biosciences. ProfitabilityThis table compares Nkarta and TuHURA Biosciences’ net margins, return on equity and return on assets. Net Margins Return on Equity Return on Assets Nkarta N/A -30.90% -24.20% TuHURA Biosciences N/A -156.12% -105.38%Insider and Institutional Ownership80.5% of Nkarta shares are owned by institutional investors.